scholarly journals Utilization of neoadjuvant intensity-modulated radiation therapy and proton beam therapy for esophageal cancer in the United States

2018 ◽  
Vol 9 (2) ◽  
pp. 282-294 ◽  
Author(s):  
Waqar Haque ◽  
Vivek Verma ◽  
E. Brian Butler ◽  
Bin S. Teh
Rare Tumors ◽  
2019 ◽  
Vol 11 ◽  
pp. 203636131987851 ◽  
Author(s):  
Nathan Y Yu ◽  
Sujay A Vora

Retroperitoneal chordomas are exceedingly rare and account for less than 5% of all primary bone malignancies. Their etiology remains unknown. We report a rare case of an extravertebral chordoma of the retroperitoneum in a 71-year-old man treated with surgical resection and post-operative spot-scanning proton beam therapy. We describe how to safely treat a retroperitoneal target to a prescription dose over 70 Gy (relative biological effectiveness) with spot-scanning proton beam therapy and also report a dosimetric comparison of spot-scanning proton beam therapy versus intensity-modulated radiation therapy. This case not only highlights a rare diagnosis of an extravertebral retroperitoneal chordoma but it also draws attention to the dosimetric advantages of proton beam therapy and illustrates a promising radiotherapeutic option for retroperitoneal targets.


Cancer ◽  
2003 ◽  
Vol 98 (1) ◽  
pp. 204-211 ◽  
Author(s):  
Loren K. Mell ◽  
John C. Roeske ◽  
Arno J. Mundt

Sign in / Sign up

Export Citation Format

Share Document